不断发展的产前筛查现状。 - Suppr

Suppr

超能文献

The evolving prenatal screening scene.

作者信息

Reddy Uma M

出版信息

Obstet Gynecol. 2007 Jul;110(1):2-4. doi: 10.1097/01.AOG.0000269044.84174.fc.

DOI:10.1097/01.AOG.0000269044.84174.fc

PMID:17601887

Abstract

摘要

相似文献

The evolving prenatal screening scene.

Obstet Gynecol. 2007 Jul;110(1):2-4. doi: 10.1097/01.AOG.0000269044.84174.fc.

Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.

Prenat Diagn. 2007 Feb;27(2):186-7. doi: 10.1002/pd.1634.

Maternal serum triple analyte screening in pregnancy.

Am Fam Physician. 2000 Aug 15;62(4):738, 740.

First- and second-trimester evaluation of risk for Down syndrome.

Obstet Gynecol. 2007 Jul;110(1):10-7. doi: 10.1097/01.AOG.0000263470.89007.e3.

Cost-effectiveness of Down syndrome screening paradigms.

Clin Lab Med. 2010 Sep;30(3):629-42. doi: 10.1016/j.cll.2010.04.007.

Antenatal screening for Down's syndrome.

Health Technol Assess. 1998;2(1):i-iv, 1-112.

Triple-marker screening for Down syndrome.

CMAJ. 1996 Aug 1;155(3):271-2; author reply 272-3.

Triple-marker screening for Down syndrome.

CMAJ. 1996 Aug 1;155(3):272; author reply 272-3.

Anomalous marker patterns in Down syndrome screening.

Prenat Diagn. 2007 Feb;27(2):185-6. doi: 10.1002/pd.1633.

Down's Syndrome screening: confusion or consensus?

BJOG. 2004 Jun;111(6):517-8. doi: 10.1111/j.1471-0528.2004.00192.x.

引用本文的文献

Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation.

BMJ. 2009 Feb 13;338:b138. doi: 10.1136/bmj.b138.

Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases.

Prenat Diagn. 2009 Jan;29(1):29-39. doi: 10.1002/pd.2127.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The evolving prenatal screening scene.

Obstet Gynecol. 2007 Jul;110(1):2-4. doi: 10.1097/01.AOG.0000269044.84174.fc.

Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.

Prenat Diagn. 2007 Feb;27(2):186-7. doi: 10.1002/pd.1634.

Maternal serum triple analyte screening in pregnancy.

Am Fam Physician. 2000 Aug 15;62(4):738, 740.

First- and second-trimester evaluation of risk for Down syndrome.

Obstet Gynecol. 2007 Jul;110(1):10-7. doi: 10.1097/01.AOG.0000263470.89007.e3.

Cost-effectiveness of Down syndrome screening paradigms.

Clin Lab Med. 2010 Sep;30(3):629-42. doi: 10.1016/j.cll.2010.04.007.

Antenatal screening for Down's syndrome.

Health Technol Assess. 1998;2(1):i-iv, 1-112.

Triple-marker screening for Down syndrome.

CMAJ. 1996 Aug 1;155(3):271-2; author reply 272-3.

Triple-marker screening for Down syndrome.

CMAJ. 1996 Aug 1;155(3):272; author reply 272-3.

Anomalous marker patterns in Down syndrome screening.

Prenat Diagn. 2007 Feb;27(2):185-6. doi: 10.1002/pd.1633.

Down's Syndrome screening: confusion or consensus?

BJOG. 2004 Jun;111(6):517-8. doi: 10.1111/j.1471-0528.2004.00192.x.

引用本文的文献

Comparison of different strategies in prenatal screening for Down's syndrome: cost effectiveness analysis of computer simulation.

BMJ. 2009 Feb 13;338:b138. doi: 10.1136/bmj.b138.

Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases.

Prenat Diagn. 2009 Jan;29(1):29-39. doi: 10.1002/pd.2127.